Shizuoka-ken, Japan

Hiromu Kondo

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 22(Granted Patents)


Location History:

  • Shizuoka, JP (2006)
  • Shizuoka-ken, JP (2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiromu Kondo: Innovator in Pharmaceutical Composition

Introduction

Hiromu Kondo is a notable inventor based in Shizuoka-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release compositions and improved absorption methods for oral medications. With a total of 2 patents to his name, Kondo's work has the potential to enhance drug delivery systems.

Latest Patents

Kondo's latest patents include a sustained-release pharmaceutical composition that features tamsulosin or its pharmaceutically acceptable salts. This invention is characterized by a specific ratio of plasma tamsulosin concentration, which is crucial for effective medication delivery. Another significant patent focuses on a pharmaceutical composition for oral use that improves absorption. This composition includes drug, aminoalkyl methacrylate copolymer E, and an acidic substance, which work together to enhance drug permeability in the digestive tract.

Career Highlights

Throughout his career, Kondo has worked with prominent companies in the pharmaceutical industry, including Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Kondo has collaborated with notable colleagues such as Kazuhiro Sako and Toyohiro Sawada, further enriching his work in the field of pharmaceuticals.

Conclusion

Hiromu Kondo's contributions to pharmaceutical compositions demonstrate his commitment to improving drug delivery and absorption methods. His innovative patents reflect a deep understanding of the complexities involved in medication formulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…